BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 1374941)

  • 1. Is the multidrug transporter a flippase?
    Higgins CF; Gottesman MM
    Trends Biochem Sci; 1992 Jan; 17(1):18-21. PubMed ID: 1374941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-glycoproteins: mediators of multidrug resistance.
    Germann UA; Pastan I; Gottesman MM
    Semin Cell Biol; 1993 Feb; 4(1):63-76. PubMed ID: 8095827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter.
    Romsicki Y; Sharom FJ
    Biochemistry; 2001 Jun; 40(23):6937-47. PubMed ID: 11389609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance: a novel class of membrane-associated transport proteins is identified.
    Gros P; Shustik C
    Cancer Invest; 1991; 9(5):563-9. PubMed ID: 1682020
    [No Abstract]   [Full Text] [Related]  

  • 5. The multidrug resistance P-glycoprotein.
    Higgins CF
    Curr Opin Cell Biol; 1993 Aug; 5(4):684-7. PubMed ID: 7903042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance due to P-glycoprotein.
    Burt RK; Fojo AT; Thorgeirsson SS
    Hosp Pract (Off Ed); 1990 Apr; 25(4):67-72, 74, 77. PubMed ID: 1969865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance in human tumors.
    Bellamy WT
    Curr Opin Oncol; 1990 Dec; 2(6):1126-32. PubMed ID: 1983090
    [No Abstract]   [Full Text] [Related]  

  • 8. Charles F. Kettering Prize. P-glycoprotein and resistance to anticancer drugs.
    Ling V
    Cancer; 1992 May; 69(10):2603-9. PubMed ID: 1348966
    [No Abstract]   [Full Text] [Related]  

  • 9. Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein.
    Gill DR; Hyde SC; Higgins CF; Valverde MA; Mintenig GM; SepĂșlveda FV
    Cell; 1992 Oct; 71(1):23-32. PubMed ID: 1382860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multidrug resistance (mdr1) gene product functions as an ATP channel.
    Abraham EH; Prat AG; Gerweck L; Seneveratne T; Arceci RJ; Kramer R; Guidotti G; Cantiello HF
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):312-6. PubMed ID: 7678345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistance: molecular biology and clinical relevance.
    Rothenberg M; Ling V
    J Natl Cancer Inst; 1989 Jun; 81(12):907-10. PubMed ID: 2567355
    [No Abstract]   [Full Text] [Related]  

  • 12. Multidrug resistance in human cancer.
    Goldstein LJ; Pastan I; Gottesman MM
    Crit Rev Oncol Hematol; 1992; 12(3):243-53. PubMed ID: 1353966
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular basis of multidrug resistance mediated by P-glycoprotein.
    Higgins CF
    Curr Opin Biotechnol; 1991 Apr; 2(2):278-81. PubMed ID: 1369467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unidirectional fluxes of rhodamine 123 in multidrug-resistant cells: evidence against direct drug extrusion from the plasma membrane.
    Altenberg GA; Vanoye CG; Horton JK; Reuss L
    Proc Natl Acad Sci U S A; 1994 May; 91(11):4654-7. PubMed ID: 7910961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate.
    Spoelstra EC; Westerhoff HV; Pinedo HM; Dekker H; Lankelma J
    Eur J Biochem; 1994 Apr; 221(1):363-73. PubMed ID: 7909520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multi-drug transporter.
    Weaver JL; Szabo G; Pine PS; Gottesman MM; Goldenberg S; Aszalos A
    Int J Cancer; 1993 May; 54(3):456-61. PubMed ID: 7685326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance: P-glycoprotein and its allies--the elusive foes.
    Chabner BA; Fojo A
    J Natl Cancer Inst; 1989 Jun; 81(12):910-3. PubMed ID: 2567356
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective growth-inhibition of multidrug-resistant CHO-cells by the monoclonal antibody 265/F4.
    Efferth T; Lathan B; Volm M
    Br J Cancer; 1991 Jul; 64(1):87-9. PubMed ID: 1677260
    [No Abstract]   [Full Text] [Related]  

  • 19. Is the multidrug resistance an ATP channel?
    Arias IM
    Hepatology; 1993 Jul; 18(1):216-7. PubMed ID: 7686878
    [No Abstract]   [Full Text] [Related]  

  • 20. Doxorubicin and multidrug resistance.
    Kruh GD; Goldstein LJ
    Curr Opin Oncol; 1993 Nov; 5(6):1029-34. PubMed ID: 7905750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.